SMS Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals has filed its yearly disclosure under SEBI's Takeover Regulations, confirming that no new pledges or encumbrances were created on promoter shares during FY 2024-25 beyond what was already disclosed. The existing encumbrance details show three promoter entities with pledged shares: Mrs. Hima Bindu Potluri has pledged 1,06,20,000 shares out of her 1,50,08,840 holdings (with another 30,00,000 shares under a Non-Disposal Undertaking), Potluri Infra Projects LLP has pledged 73,46,420 of its 88,46,420 shares, and Potluri Laboratories Private Limited has its entire 11,20,320 holding fully pledged. In total, roughly 1.91 crore promoter shares stand pledged, representing about 76% of the disclosed promoter shareholdings.
The disclosure itself is routine, but the data reveals that promoter share pledging is very high (over 75% of promoter holdings), which is a risk factor retail investors should monitor closely — any invocation of these pledges or forced sales could pressure the stock price.